Literature DB >> 7651839

Identification of human autoantibodies to transcription factor IIB.

F D Abendroth1, S R Peterson, M Galman, A Suwa, J A Hardin, W S Dynan.   

Abstract

We have characterized the ability of various human autoimmune sera to react with RNA polymerase II transcription factors. One serum, which strongly inhibited transcription in a cell-free system, was shown to contain antibodies directed against human TFIIB. The serum did not show reactivity against the other general transcription factors, including human TBP, TFIIE and TFIIF. The inhibition of transcription was directly attributable to depletion of TFIIB activity, as demonstrated by reconstitution of activity with recombinant TFIIB. It has long been recognized that components of the RNA processing machinery are major human autoantigens. The present results show that at least one general transcription factor required for messenger RNA synthesis is an autoantigen as well.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651839      PMCID: PMC307103          DOI: 10.1093/nar/23.14.2770

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  27 in total

Review 1.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  Characterization by human antibodies of two HeLa cell proteins which are related to Xenopus laevis transcription factor TFIIIA.

Authors:  S Lagaye; J P Barque; M le Maire; H Denis; C J Larsen
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

3.  GAL4 derivatives function alone and synergistically with mammalian activators in vitro.

Authors:  Y S Lin; M F Carey; M Ptashne; M R Green
Journal:  Cell       Date:  1988-08-26       Impact factor: 41.582

4.  Promoter-dependent transcription by RNA polymerase II using immobilized enzyme complexes.

Authors:  J A Arias; W S Dynan
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

5.  Molecular cloning of cDNA encoding the p70 (Ku) lupus autoantigen.

Authors:  W H Reeves; Z M Sthoeger
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

6.  A small nuclear ribonucleoprotein is required for splicing of adenoviral early RNA sequences.

Authors:  V W Yang; M R Lerner; J A Steitz; S J Flint
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

7.  Stimulation of the DNA-dependent protein kinase by RNA polymerase II transcriptional activator proteins.

Authors:  S R Peterson; S A Jesch; T N Chamberlin; A Dvir; S K Rabindran; C Wu; W S Dynan
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

8.  Autoantibody to RNA polymerase I in scleroderma sera.

Authors:  G Reimer; K M Rose; U Scheer; E M Tan
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

9.  Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III.

Authors:  E Gottlieb; J A Steitz
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

10.  The RNA binding protein La influences both the accuracy and the efficiency of RNA polymerase III transcription in vitro.

Authors:  E Gottlieb; J A Steitz
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.